The pumpers want to stick you with their overpriced bags.
If a trial does not meet the endpoints, it FAILED.
Cherry picking subgroup data does not make it a success.
That's equivalent to losing a game 8 to 2 but if you just look at just the third inning when the losing team scored 2 runs to zero, they won the game.
If the cancer does not progress in 2 patients out of 100, the trial is a failure. Finding a commanality between the two patients and stating that the drug is effective for males between the age of 62 and 64 with blue eyes is nothing more than tom foolery.
Peddling Neuvax, the failed drug that was purchased for $7M, as a successful potential blockbuster is tantamount to a scam.
Institutional ownership is reported quarterly.
The 24% was on 12/31.
If you take out the Index Funds, institutional holdings were quite small.
The pps has been tanking recently, that would suggest that institutional holdings will show a decrease for this quarter when it is reported.
He wrote an essay in a condescending tone and made faulty assumptions and projections.
Subsys sales increased smartly in the last quarter, so he's hallucinating if he thinks that they are losing sales to Abstral.
Subsys is flying off the shelfs but the pharmacists hate it? Does he just make this stuff up?
What is the expenditure for hiring, training and paying 145 sales reps?
Before Abstral gains any traction it will be a huge drain on resources and speed the need for another financing.
Galena doesn't have experience marketing anything. The jury is out whether they can turn it into a success.
It's wise to be skeptical until they prove something. Declaring Abstral a breakout medication is sheer foolishness.
Conferences are a big yawn.
They are an all expenses paid junket for the CEO.
There's never any new news at the conferences.
More often than not, the CEO goes to get in contact with an underwriting firm.
A dilutive financing is probably headed your way.
What fundamentals? Those that the DreamTean drummed into you empty head?
Neuvax is a failed drug that is now being tried on a cherry picked subgroup.
Abstral has lots of entrenched competitionin a modest market space by a company that has never marketed anything, and the patent expires in 2019.
The fundamentals always sucked and the insider sales confirm that.
Do you know what HYPE is?
It's outlandish projections to entice gullible saps to pay $800M for scrap heap dung that was purchased for $20M.
Did the DreamTeam point out that Ahn previously ran Hana Bio into the ground, that the "miracle" drugs were actually other companies' rejects purchased by GALE off the junk pile or that the cherry picked sub group data is suspect?
Ohhhhhh, the institutions BS.
News flash, institutions own stock in every listed company.
They even owned loads of Enron, Worlcom, Lehman, Kodak ...........
You think that gives you cover? The pps still dropped from $7.77, did it not?
Your list of institutions contains mainly INDEX FUNDS.
Do you know why Index Funds hold GALE shares? Because they must!
It's not an endorsement of the stock.
GALE has gotten nothing approved through the FDA process.
They bought other companies reject drugs for $20M and flipped them to you for $800M.
The DOJ and SEC aren't there to prevent you from overpaying for dung in the market place.
The law firms will try to help you in the pending class action lawsuits, but alas, they will keep most of the bounty.
You will just have to write off your losses as a lesson learned.
It's based on what your fellow pumper posted"
"....if Subsys Rx/Revenue are stagnant or declining this would bode very well for Abstral/GALE because it means that Abstral picked up more and more market share. We will know this fact on Tuesday when Insys will report its sales before market opens.
We now know that Subsys is capturing market share.
What is the new spin regarding Abstral now?
It was misleading HYPE to get imbeciles like you to pay $500M to $800M for other companies rejects that GALE picked up for about $20M.
over the past year.
insiders bailing shows that it was all lies, hype, smoke and mirrors.
You are in denial that you were conned. You can't face the fact that you are gullible saps and easy pickings for the boiler room hucksters.